Literature DB >> 18406281

The vitamin d receptor gene and calcium metabolism.

S Ferrari1, J P Bonjour, R Rizzoli.   

Abstract

Dietary Ca(2+) is essential for the development and maintenance of bone mineral mass. The vitamin D endocrine system plays a fundamental role in the regulation of Ca(2+) homeostasis, and mutations affecting genes implicated in vitamin D metabolism or vitamin D receptor (VDR) functions are responsible for severe alterations in skeletal growth. In addition, vitamin D is also implicated in the pathophysiology and treatment of adult bone disorders associated with impaired mineralization of bone matrix. Very recently, common polymorphisms in the 3'- and 5'-end region of the VDR gene have been suggested as possible determinants of bone mineral mass and, hence, of the risk of osteoporosis. None of these polymorphisms appear to be associated unequivocally with bone mineral mass or biochemical variables of Ca(2+) and phosphate metabolism, except perhaps VDR 3'-end polymorphisms before puberty. As these associations are so inconsistent, interactions with environmental factors, particularly dietary intake, and with other polymorphisms have to be considered.

Entities:  

Year:  1998        PMID: 18406281     DOI: 10.1016/s1043-2760(98)00065-4

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  11 in total

Review 1.  Genetic determinants of bone strength and fracture in humans: dreams and realities.

Authors:  Sergio Livio Ferrari
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

2.  Amyloid Beta 1-42 Alters the Expression of miRNAs in Cortical Neurons.

Authors:  Erdinç Dursun; Esin Candaş; Selma Yılmazer; Duygu Gezen-Ak
Journal:  J Mol Neurosci       Date:  2018-12-04       Impact factor: 3.444

3.  Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis.

Authors:  Israr Ahmad; Tabrez Jafar; Farzana Mahdi; Md Arshad; Siddharth Kumar Das; Shah Waliullah; Abbas Ali Mahdi
Journal:  Indian J Clin Biochem       Date:  2017-10-28

4.  Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels.

Authors:  Aparna A Bhanushali; Namrata Lajpal; Smita S Kulkarni; Sandeep S Chavan; Sarita S Bagadi; Bibhu R Das
Journal:  Indian J Hum Genet       Date:  2009-09

5.  FokI and BsmI polymorphisms of the vitamin D receptor gene and bone mineral density in a random Bulgarian population sample.

Authors:  Jivka Ivanova; Polet Doukova; Mihail Boyanov; Plamen Popivanov
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.925

6.  The influence of vitamin D receptor genetic variants on bone mineral density and osteoporosis in Chinese postmenopausal women.

Authors:  Wei He; Ming Liu; Xiaonan Huang; Zuhong Qing; Wei Gao
Journal:  Dis Markers       Date:  2015-02-17       Impact factor: 3.434

7.  25-Hydroxyvitamin D3 Levels, BsmI Polymorphism and Insulin Resistance in Brazilian Amazonian Children.

Authors:  Fernanda Cobayashi; Bárbara Hatzlhoffer Lourenço; Marly Augusto Cardoso
Journal:  Int J Mol Sci       Date:  2015-06-03       Impact factor: 5.923

8.  Associations of vitamin D deficiency and vitamin D receptor (Cdx-2, Fok I, Bsm I and Taq I) polymorphisms with the risk of primary open-angle glaucoma.

Authors:  Yingjuan Lv; Qingbin Yao; Wenjiang Ma; Hua Liu; Jian Ji; Xiaorong Li
Journal:  BMC Ophthalmol       Date:  2016-07-19       Impact factor: 2.209

Review 9.  A comprehensive overview on osteoporosis and its risk factors.

Authors:  Farkhondeh Pouresmaeili; Behnam Kamalidehghan; Maryam Kamarehei; Yong Meng Goh
Journal:  Ther Clin Risk Manag       Date:  2018-11-06       Impact factor: 2.423

10.  Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women.

Authors:  Shilpi Dasgupta; Joyita Dutta; Sandhya Annamaneni; Neelaveni Kudugunti; Mohan Reddy Battini
Journal:  Indian J Med Res       Date:  2015-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.